Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study
- PMID: 32639942
- DOI: 10.1515/cclm-2020-0962
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study
Keywords: COVID-19; SARS-CoV-2; kinetics; serology; symptom onset.
References
-
- Bohn, MK, Lippi, G, Horvath, A, Sethi, S, Koch, D, Ferrari, M, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 2020;10:1037–52. https://doi.org/10.1515/cclm-2020-0722.
-
- Zhao, J, Yuan, Q, Wang, H, Liu, W, Liao, X, Su, Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020;28:1–22. https://doi.org/10.1093/cid/ciaa344.
-
- Farnsworth, CW, Anderson, NW. SARS-CoV-2 serology: much hype, little data. Clin Chem 2020. [Online ahead of print]. https://doi.org/10.1093/clinchem/hvaa107.
-
- Vashist, SK. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics (Basel) 2020;10:202. https://doi.org/10.3390/diagnostics10040202.
-
- Diamandis, P, Prassas, I, Diamandis, EP. Antibody tests for COVID-19: drawing attention to the importance of analytical specificity. Clin Chem Lab Med 2020;58:1144–45. https://doi.org/10.1515/cclm-2020-0554.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous